abstract |
The present invention relates to a composition for inhibiting CTGF expression, the composition enabling the inhibition of the expression level of CTGF by means of RNA interference (RNAi), and the present invention relates to a composition enabling the prevention or treatment, with excellent efficiency, of various fibroplastic diseases such as hypertrophic scars and keloids. |